The US Food and Drug Administration may be willing to sit down with a company about a possible NDI submission for full-spectrum hemp extracts, says Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN).
An amendment to a military funding bill would make it possible for military personnel to openly use hemp/CBD products for the first time. While advocates welcome the development, there is little prospect that CBD products will become part of standard...
FDA has stated it is making ‘substantial progress’ with CBD, and a new enforcement guidance could be very significant for the industry, said NPA’s Dr Daniel Fabricant, but he said the Agency needs to ‘get in the game’ for NDIs.
Clorox, a major manufacturer of dietary supplements and household products, has partnered with the Cleveland Clinic on a guide to help businesses cope with coronavirus provisions in the workplace.
Making nutrition understandable for everyone is the goal of the Label Wise initiative led by the Council for Responsible Nutrition. That made it a clear choice for this year’s Editors Award for Industry Initiative of the Year.
An additional seven supplement companies have been added recently to the US Food and Drug Administration’s list of firms making allegedly non compliant COVID-19 treatment claims.
Suzanne Shelton, a winner of a NutraIngredients-USA NutraChampion 2020 award, took an alternative path early in life as a groundbreaking Chicago DJ and rode that rhythm into becoming one of the leading voices within the natural products industry.
After pausing on-site surveillance inspections in March, the Food and Drug Administration plan to resume domestic inspections starting the week of July 20.
Recent cyberattacks on a contract lab and a contract manufacturer lay bare the risk all data-based businesses run in a globalized world where threats can come from anywhere and can potentially be motivated by factors beyond mere financial gain.
A new publication from the Botanical Adulterants Prevention Program reveals that as many as 90% of the lavender essential oil products on the market can be considered to be adulterated.
An FDA report on the CBD marketplace reveals that many of the products tested contain THC that was not identified on the labels. In addition, a majority of the products did not meet label claim for CBD content, with either too little or too much CBD.
The bioactivity of commercial bovine colostrum samples may vary significantly, says a new study partially funded by colostrum-based nutrition company, PanTheryx, which the company says aims to shine a spotlight on sourcing and handling.
A recent warning letter reiterates the importance of collecting adverse event reports in order to demonstrate full compliance with federal laws governing the manufacture and sale of dietary supplements.
